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OBJECTIVES The purpose of this study was to investigate the possible mechanism and the clinical
significance of transient atrioventricular block (AVB) during dobutamine stress echocardi-
ography (DSE).
BACKGROUND Transient AVB occurs rarely during DSE; however, the mechanisms responsible for blocks
are unclear.
METHODS A retrospective analysis of clinical, echocardiographic, catheterization, revascularization and
head-up tilting test data was conducted in patients who developed transient AVB during
DSE.
RESULTS A total of 302 patients with known or suspected coronary artery disease (CAD) underwent
DSE before coronary angiography between November 1997 and August 1998. Transient
AVB developed in 12 patients during the test. Mobitz I block was noted in six patients and
Mobitz II block in the other six patients. Nine of these 12 patients were subsequently shown
to have CAD and three had no significant coronary artery stenosis. Mobitz II block was
observed only in patients with CAD, while Mobitz I block occurred in three patients with and
three patients without CAD (p , 0.05). Eight of the nine patients with CAD underwent a
successful coronary angioplasty with or without stenting and a repeat DSE revealed no
recurrence of heart block except in one patient. Head-up tilting test in the 12 patients revealed
a positive response in three of the nine patients with and all three patients without CAD. A
negative head-up tilting test was likely to be observed in patients with, as compared with
those without, CAD in this study population (p , 0.05).
CONCLUSIONS Transient AVB is not an infrequent manifestation during DSE. Both myocardial ischemia
and neurally mediated vagal reflex may be responsible for this phenomenon. The development
of Mobitz II block during DSE is indicative of the presence of CAD. A successful
revascularization in patients with CAD who develop transient AVB may abolish this
phenomenon. (J Am Coll Cardiol 1999;34:998–1004) © 1999 by the American College of
Cardiology
Dobutamine stress echocardiography (DSE) is an effective
and safe tool for diagnosis of coronary artery disease (CAD)
(1–4). The most common adverse experiences during DSE
are angina pectoris and arrhythmias, which are usually mild
and well-tolerated by the patients without specific treatment
(5–7). Transient atrioventricular block (AVB) during DSE
has been described only occasionally (5,6), but the mecha-
nism and significance of transient AVB during DSE have
not been elucidated. This study was conducted to investi-
gate the possible mechanism and the clinical significance of
transient AVB during DSE.
METHODS
Patients. From November 1997 through August 1998, 302
patients underwent DSE for evaluation of CAD at Chang
Gung Memorial Hospital in Taipei, Taiwan. Twelve (4%)
of the 302 patients who developed transient second degree
AVB during DSE were the population of this study. All
study patients received cardiac catheterization and coronary
angiography within two days after DSE. Percutaneous
transluminal coronary angioplasty (PTCA) with or without
stenting was performed to lesions with $50% stenosis.
Follow-up DSE was performed in patients who had a
successful coronary revascularization three to seven days
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later. A head-up tilting test was performed in all patients.
The study was retrospective in nature and the protocol of
DSE was reviewed and approved by the institutional review
board and was in accordance with the local ethical stan-
dards.
DSE. Dobutamine stress echocardiography was performed
using a Vingmed CFM 800 system (Vingmed Sound,
Horten, Norway) with a 2.5-MHz transducer. Images were
acquired from parasternal long- and short-axis views as well
as apical two- and four-chamber views, with the patient in
the left lateral recumbent position. After recording the
baseline echocardiography, dobutamine was administered
intravenously by an infusion pump at 5 mg/kg body weight
per min for 3 min, which was subsequently increased at a
step of 10 mg/kg per min every 3 min to a maximum of
40 mg/kg per min. Atropine (0.25 mg per min to a
maximum of 1 mg) was then injected if 85% of the predicted
maximal heart rate (220 minus age for men and 200 minus
age for women) was not reached. A 3-lead electrocardiogram
(ECG) was continuously monitored and the blood pressure
was measured by an automatic device every 3 min. The
echocardiogram was continuously monitored throughout the
test, recorded on videotape and digitized on floppy disk which
could be displayed side by side in a quad screen format to
facilitate the comparison of the images at various stages. The
test was discontinued if severe angina pain, achievement of
85% of the predicted maximal heart rate, extensive new wall
motion abnormalities, ST segment elevation .0.1 mV, severe
hypertension (blood pressure $240/120 mm Hg), hypotension
(decrease in systolic blood pressure $40 mm Hg), significant
tachyarrhythmias or other intolerable side effects developed
during the test. In the event of severe angina and manifestation
of ischemia, sublingual nitroglycerin or intravenous esmolol or
both were administered.
Analysis of echocardiography. The wall motion was ana-
lyzed by dividing the left ventricle into 16 segments, as
recommended by the American Society of Echocardiogra-
phy (8). Regional wall motion was semiquantified using a
4-point scoring system: 1 5 normal contraction, 2 5
hypokinesia, 3 5 akinesia, 4 5 dyskinesia. Global wall
motion score index (WMSI) at each stage was calculated
according to the standard formula: sum of the segment
scores/number of segments scored. A positive test was
defined as the development of a new or worsening of wall
motion dyssynergy. In addition, a biphasic response with an
initial improvement of dyssynergy followed by worsening of
dyssynergy was considered as a positive test.
Coronary angiography and revascularization. Coronary
angiography using the Judkins technique was performed
within one to two days after DSE. The severity of coronary
stenosis was determined by calipers and expressed as a
percent of luminal diameter reduction to the nearby normal
segment. Significant CAD was defined as $50% stenosis of
at least one epicardial artery.
Coronary angioplasty with or without stent implantation
was performed on all lesions with significant stenosis using
standard techniques through the femoral artery. Successful
revascularization was defined as $20% reduction in luminal
diameter stenosis with ,50% final residual diameter steno-
sis. Complete revascularization was defined when all dis-
eased vessels displayed no residual stenosis $50% in all
coronary arteries.
Follow-up DSE. Follow-up DSE was performed in those
patients with successful coronary revascularization within
three to seven days. The hemodynamic variables and WMSI
were compared before and after revascularization in these
patients.
Head-up tilting test. The head-up tilting test was per-
formed several days after coronary angiography or coronary
revascularization in all patients after fasting for at least 8 h.
All cardiovascular drugs were discontinued 48 h before the
test. The ECG was continuously displayed and the blood
pressure measured at 2-min intervals. After a 10-min resting
period in supine position, the patients were elevated to an
80° head-tilt position for 5 min. If syncope, bradycardia or
hypotension was not observed, the same procedure was
repeated with isoproterenol infusion at a stepwise dose
increment of 1, 2 and 4 mg/min sequentially. A positive
head-up tilting test was defined as the development of
near-syncope or syncope in association with bradycardia,
hypotension or both. Bradycardia was defined as the heart
rate below 60 beats/min and a decline in the heart rate by at
least 20 beats/min from the baseline value. Hypotension was
considered when the absolute systolic blood pressure was
less than 90 mm Hg or the decrease in systolic blood
pressure was more than 50% of the maximal value observed
in the upright position (9,10).
Definitions. Mobitz I block is a type of second degree
AVB with progressive lengthening of PR (interval between
p wave and QRS complex) interval before a blocked P wave,
while Mobitz II block is a sudden unexpected blocked
P wave without changes in PR interval. For the purpose of
analysis, 2:1 or high grade AVB associated with Mobitz I
block was analyzed as Mobitz I block, while 2:1 or high
Abbreviations and Acronyms
AV 5 atrioventricular
AVB 5 atrioventricular block
CAD 5 coronary artery disease
DSE 5 dobutamine stress echocardiography
ECG 5 electrocardiogram
LVEF 5 left ventricular ejection fraction
PTCA 5 percutaneous transluminal coronary
angioplasty
PR 5 interval between p wave and QRS complex
WMSI 5 wall motion score index
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grade AVB without changes in PR interval or Mobitz I
block was analyzed as Mobitz II block.
Statistical analysis. Data are expressed as mean 6 SD.
Paired Student t test was used for comparison of paired
data. Differences between the groups with and without
CAD were assessed by chi-square analysis. Student t tests
were used to assess the association of each variable sepa-
rately for the patients with and without transient AVB. A
value of p , 0.05 was considered statistically significant.
RESULTS
Clinical characteristics (Table 1). All 12 patients were
men with an average age of 51 6 12 years (range 32–72).
Five patients had angina pectoris, 4 had recent myocardial
infarction, 1 had congestive cardiomyopathy with an ECG
suggestive of old myocardial infarction and 2 had atypical
chest pain. The baseline ECG was normal in five patients
and displayed anterior myocardial infarction in four patients
and inferior myocardial infarction in three patients. All 12
patients were in sinus rhythm with 1:1 atrioventricular (AV)
conduction and normal PR interval. Mobitz type I Wenck-
ebach block developed in six patients and Mobitz type II
block developed in the other six patients during DSE (Fig.
1); one of the type I (case 9) and two of the type II block
(cases 2 and 7) were associated with 2:1 AVB. Atrioven-
tricular block appeared during dobutamine infusion at a
dose of 20 mg/kg per min in 1 patient, 30 mg/kg per min in
two patients and at 40 mg/kg per min in 9 patients. The
sinus rate at the time of AVB was 74 6 16 beats/min as
compared with a rate of 61 6 9 beats/min during control.
The duration of transient AVB ranged from 0.75 to
3.93 min. One to one AV conduction resumed after
intravenous injection of atropine in the six patients with
type I AVB, but not in the six patients with type II AVB.
In the latter six patients, 1:1 AV conduction resumed after
discontinuance of dobutamine.
Coronary angiography and revascularization (Table 2).
Coronary angiography demonstrated two-vessel disease in
seven patients, one-vessel disease in two patients and patent
coronary arteries in the remaining three patients (cases 9, 10
and 12). The lesion was noted in the left anterior descend-
ing artery in 5, the circumflex artery in 4 and the right
coronary artery in 7. The AV nodal artery was visible in all
patients except the 5 patients (cases 2, 4–6 and 11) who had
a total occlusion of the right coronary artery. The left
ventricular ejection fraction (LVEF) ranged from 0.31 to
Figure 1. Electrocardiographic tracings showing Mobitz type I
second degree atrioventricular block in case 11 (A) and Mobitz
type II block in case 2 (B) during dobutamine stress echocardiog-
raphy. Arrow indicates p wave.
Table 2. Summary of Coronary Angiography, Cardiac Catheterization and Revascularization in 12 Patients With Transient
Atrioventricular Block
Coronary Angiography (% Diameter Stenosis) Left Ventriculography
Case LM LAD LCX RCA EF RWM Revascularization
1 Normal 100 55 Normal 0.71 Normal Stenting to LAD
2 Normal 77 Normal 100 0.56 Inf akinesia Failed
3 Normal 65 Normal 66 0.57 Ant hypokinesia Stenting to LAD and RCA
4 Normal Normal 69 100 0.65 Normal Stenting to RCA and angioplasty
to LCX
5 Normal Normal Normal 100 0.53 Inf hypokinesia Angioplasty to RCA
6 Normal Normal 82 100 0.77 Normal Stenting to LCX and RCA
7 Normal 74 Normal 73 0.31 Ant hypokinesia and
apical akinesia
Stenting to LAD and RCA
8 Normal 83 Normal Normal 0.53 Apical akinesia Angioplasty to LAD
9 Normal Normal Normal Normal 0.57 Normal None
10 Normal Normal Normal Normal 0.68 Normal None
11 Normal Normal 76 100 0.43 Inf hypokinesia Stenting to LCX and RCA
12 Normal Insignificant Normal Normal 0.41 Ant hypokinesia and
Inf akinesia
None
Ant 5 anterior; EF 5 ejection fraction; Inf 5 inferior; LAD 5 left anterior descending artery; LCX 5 left circumflex artery; LM 5 left main artery; RCA 5 right coronary
artery; RWM 5 regional wall motion.
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0.77 and was normal in nine patients and abnormal in three
patients. Wall motion abnormality with local hypokinesia or
akinesia was observed in seven patients. Coronary revascu-
larization with balloon angioplasty and stent implantation
was performed in the nine patients with significant CAD
and was successful in 8 patients. Complete revascularization
was achieved in 7 of the latter 8 patients except 1 patient
(case 1) who had a residual 55% stenosis in the left
circumflex artery. After angioplasty or stenting, the AV
nodal artery was visible in all patients except the one (case 2)
who had an unsuccessful revascularization.
DSE before and after revascularization (Table 1). Do-
butamine stress echocardiography was performed in all 12
patients with or without CAD before coronary angiography
and it was repeated in the eight patients who had CAD but
with successful revascularization. Dobutamine stress echo-
cardiography demonstrated abnormal wall motion with and
without new wall motion abnormalities in 10 of the 12
patients before coronary angiography. Nine of these 10
patients exhibited a CAD by angiogram. Mobitz II AVB
developed only in the 6 patients with CAD while Mobitz I
AVB occurred in 3 patients with and 3 patients without
(x2 5 4, p , 0.05). In the 10 patients with CAD, new wall
motion abnormalities were noted during DSE in 8 patients.
In 6 of these 8 patients (cases 1, 3, 4, 6, 7 and 12), AVB
occurred concomitantly with the onset of new wall motion
abnormalities, while in the other 2 patients (cases 8 and 11)
it occurred before the onset of new wall motion abnor-
malities. The repeat DSE in the eight patients with
successful revascularization displayed an improvement in
the WMSI at rest (1.22 6 0.23 before and 1.13 6 0.20
after revascularization, p 5 0.02) and during peak dose of
dobutamine (1.41 6 0.23 before and 1.13 6 0.20 after
revascularization, p 5 0.001). Only one patient devel-
oped AVB during the follow-up DSE (case 11); this
patient had Mobitz I block before and after revascular-
ization. In this patient, AVB occurred before the onset of
new wall motion abnormalities before revascularization.
After revascularization, there were no new wall motion
abnormalities during DSE.
Head-up tilting test (Table 1). The head-up tilting test
was conducted in all 12 patients. Six displayed a positive
response. Three of these 6 patients had CAD and 3 had
patent coronary arteries. Four of these six patients mani-
fested with Mobitz I AVB and 2 with Mobitz II AVB
during DSE. All 6 patients developed hypotension and
severe sinus bradycardia during head-up tilting; 2 experi-
enced syncope and 4 experienced near-syncope. None of
these six patients developed AVB during the head-up tilting
test. A negative head-up tilting test was observed to be more
common in patients with CAD than it was in those without
in this group of patients who developed transient AVB
during DSE (chi-square 5 4, p , 0.05).
Clinical and stress echocardiographic parameters in pa-
tients with and without AVB (Table 3). There were no
significant differences between patients with and without AVB
in gender, cardiac risk factors, previous myocardial infarction,
incidence of CAD and medications; however, patients with
AVB were younger. There were also no significant differences
in the stress echocardiographic parameters between these two
groups, including symptoms, heart rate, blood pressure,
LVEF, WMSI and new wall motion abnormalities.
DISCUSSION
Transient AVB is a relatively rare complication during DSE
with a reported incidence ranging from 0.6% to 1.1% (5,6).
The nature of this complication had not been investigated
previously. Transient AVB has been known to occur spon-
taneously in patients without obvious structural heart disease
(11). The type of block is Mobitz type I, usually occurring at
midnight, and is associated with sinus bradycardia. Paroxysmal
AVB may also occur during exercise in patients with latent
disease in the His-Purkinje system (12). In the present series,
transient AVB occurred in 4% of patients who underwent a
DSE test before coronary angiography and both Mobitz I and
Mobitz II block were observed.
Myocardial ischemia and AVB. Mobitz type I second
degree AVB is a common manifestation of acute inferior
Table 3. Clinical and Dobutamine Stress Echocardiographic
Parameters in Patients With and Without AVB
AVB
(n 5 12)
No AVB
(n 5 290)
p
value
Age (yr) 51 6 12 59 6 11 0.01
Male 12 (100%) 245 (85%) 0.36
Hypertension 4 (33%) 97 (33%) 0.99
Diabetes mellitus 2 (17%) 37 (13%) 0.75
Hypercholesterolemia 3 (25%) 100 (35%) 0.50
Previous MI 6 (50%) 138 (48%) 0.87
CAD 9 (75%) 174 (60%) 0.30
Medication
Beta-blockers 10 (83%) 183 (63%) 0.15
Calcium-blockers 2 (17%) 58 (20%) 0.78
Stress echocardiography
Chest pain 4 (33%) 62 (21%) 0.33
Headache 2 (17%) 18 (6%) 0.15
Nausea 1 (8%) 6 (2%) 0.16
Rest HR (beats/min) 61 6 9 66 6 11 0.09
Peak HR (beats/min) 129 6 28 127 6 23 0.73
Rest SBP (mm Hg) 118 6 15 128 6 20 0.08
Peak SBP (mm Hg) 187 6 15 177 6 36 0.33
Rest LVEF (%) 56 6 13 59 6 11 0.31
Rest WMSI 1.18 6 0.24 1.18 6 0.25 0.92
Peak WMSI 1.35 6 0.22 1.23 6 0.27 0.14
New WMA 8 (67%) 143 (49%) 0.45
AVB 5 atrioventricular block; CAD 5 coronary artery disease; HR 5 heart rate;
LVEF 5 left ventricular ejection fraction; MI 5 myocardial infarction; SBP 5
systolic blood pressure; WMA 5 wall motion abnormalities; WMSI 5 wall motion
score index.
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wall infarction because the AV nodal artery arises from the
dominant coronary artery at the origin of the posterior
descending artery (13). However, the distal AV node may
also receive collateral blood supplies from the septal perfo-
rating arteries of the proximal left anterior descending artery
(14). Bassan et al. (15) analyzed 51 consecutive patients with
acute inferior wall infarction and noted some degree of AVB
in 11 patients. They found that patients with inferior
infarction and proximal left anterior descending artery
lesion had a six-fold greater chance of developing block
during acute phase of infarction as compared with those
without left anterior artery lesion. In contrast, Mobitz type
II second degree AVB is a less common complication of
acute myocardial infarction and is usually associated with
extensive anteroseptal infarction because the His bundle and
the proximal bundle branches receive blood supplies from
the septal perforating arteries of the left anterior descending
artery as well as the posterior descending artery and the AV
nodal artery (16). Atrioventricular block, regardless of the
type or site of the block complicating acute infarction, is
usually transient; the AV conduction resumes during recov-
ery phase of infarction. Histologic studies in patients who
had succumbed to acute infarction complicated by AVB
usually revealed interstitial edema and cell swelling with
only scattered necrosis of the conducting tissue (17). These
findings suggest that conducting tissue survives better than
the working myocardial cells and ischemia, edema, in-
creased vagal tone or the effects of endogenous adenosine
may contribute to the occurrence of AVB during acute
infarction. Wilber et al. (18) reported two patients with
complete heart block complicating extensive anterior myo-
cardial infarction in whom a late angioplasty was performed.
One to one AV conduction resumed within minutes of
reperfusion despite a lack of measurable ventricular muscle
salvage as demonstrated by ventriculography one week later.
Moreyra et al. (19) reported a patient with congestive heart
failure and complete AVB with no evidence of acute
infarction. Coronary angiography revealed a 95% stenosis of
the middle third of the right coronary artery, 50% stenosis of
the left main coronary artery and 50% stenosis of the
proximal left anterior descending artery. Coronary angio-
plasty to the right coronary artery was conducted one week
after the onset of AVB. Within 24 h after reperfusion, 1:1
AV conduction with first degree block was observed. Four
days after reperfusion, the PR interval returned to normal.
Kovac et al. (20) described a patient with recurrent syncope
and episodes of paroxysmal AVB preceded by asymptomatic
ST elevation on ambulatory monitoring. Coronary angiog-
raphy revealed a severe stenosis in the midsegment of the
right coronary artery. Successful angioplasty with stent
implantation abolished the episodes of syncope and AVB.
Vagally-mediated AVB. Vagally-mediated paroxysmal
AVB has been observed during vomiting (21), swallowing
(22), carotid massage (23) and coronary angiography (24). It
has also been observed during the head-up tilting test (25).
The head-up tilting test is a very useful diagnostic tool in
patients with neurocardiogenic or vasovagal syncope
(9,10,26,27). Although the methodology of this test varies,
it requires patients to be tilted to a semiupright position
using a motorized table with a footboard. If hypotension or
bradycardia are not observed during the observation period,
the test is repeated during isoproterenol infusion. Although
the exact mechanism of head-up tilting test is not entirely
clear, the test is probably operating through the Bezold-
Jarisch axis (26,27). The Bezold-Jarisch reflex results from
stimulation of the inhibitory cardiac sensory receptors that
lead to vagal activation and sympathetic inhibition, produc-
ing vasodilation, hypotension and bradycardia (28). Pro-
longed asystole due to sinus arrest or sinoatrial block is
common, but AVB is rare, probably due to the accompa-
nying sinus bradycardia (24,25). The Bezold-Jarisch reflex
may play a role in the genesis of AVB during myocardial
ischemia or the acute phase of infarction (28).
AVB during DSE. This study showed that AVB occurred
during DSE in both patients with and without CAD and
that both Mobitz type I and Mobitz type II block were
observed during AVB. Mobitz type II block was observed
only in patients with CAD, usually in those with left
anterior descending artery disease or those with two-vessel
disease. In contrast, Mobitz type I block was noted in
patients with and without CAD. Several mechanisms could
be operating. First, myocardial ischemia induced by dobut-
amine infusion was the most likely mechanism responsible
for AVB in patients with CAD. The observation that AVB
developed concomitantly with the onset of new wall motion
abnormalities is consistent with this hypothesis. The aboli-
tion of AVB during repeat DSE following successful revas-
cularization further supports this assumption. Second, va-
gally mediated effects could be a contributing factor in some
patients. Although dobutamine instead of isoproterenol was
used in stress echocardiography, dobutamine could initiate
vagal reflex through the Bezold-Jarisch reflex. The finding
that all three patients without CAD had a positive head-up
tilting test and that all three manifested with Mobitz I block
during DSE is consistent with this assumption. However,
the fact that AVB is a rare manifestation of the head-up
tilting test appears to be contradictory to this hypothesis.
This may be explained by the accompanying sinus brady-
cardia during head-up tilting which prevented the occur-
rence of AVB (24,25). Last, there may be latent disease in
the conducting system. If this is the case, dobutamine
infusion could unravel the abnormality in the His-Purkinje
system producing Mobitz type II block, while enhancing the
AV nodal conduction preventing the occurrence of Mobitz
type I block. This possibility is less likely because the block
in patients with CAD disappeared after revascularization,
while the block in those without CAD was a Mobitz type I
AV nodal block.
Conclusions. This study demonstrates that transient sec-
ond degree AVB is not an infrequent complication during
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DSE. Both Mobitz type I and Mobitz type II blocks may be
observed. The occurrence of Mobitz type II block during
DSE is indicative of the presence of CAD, usually involving
the left anterior descending artery or two coronary arteries.
Mobitz type I block may occur in both patients with and
without CAD. In patients with CAD and development of
AVB during DSE, successful revascularization may abolish
the occurrence of AVB.
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